Latest Breaking News On - Frequency therapeutic - Page 1 : comparemela.com

Cormorant Asset Management, LP Acquires New Stake in Frequency Therapeutics Inc

Cormorant Asset Management, LP (Trades, Portfolio), a notable investment firm, has recently expanded its portfolio by purchasing shares in Frequency Therapeutics Inc (NASDAQ:FREQ). The transaction, which took place on November 6, 2023, saw Cormorant Asset Management acquiring 679,170 shares at a price of $0.2996 per share. The firm now holds an 8.49% stake in Frequency Therapeutics, indicating a significant level of confidence in the biotechnology company's prospects.

United statesFrequency therapeutics inc overviewFrequency therapeutics incFinancial analysis of frequency therapeutics incTherapeutics incProgenitor cell activationFrequency therapeuticsFrequency therapeuticProfitability rankGrowth rankAsset managementCormorant asset managementBiotechnology companyAsset managementApellis pharmaceuticals incHealthcare sector

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger

Frequency Change: Korro Bio Edits Its Message, Rewrites Its Future with Reverse Merger
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAlex silversteinVenkat krishnamurthyStephanie engelsNessan berminghamKorro bioDavidl lucchinoTodd chappellWoodruff sawyerRam aiyarVineet agarwalSteve collettiAndrew fraleyJosh rosenthalShelby walker

With Korro Bio merger in works, Frequency stops program for MS | Company looking for ways to monetize lead remyelination therapy

With Korro Bio merger in works, Frequency stops program for MS | Company looking for ways to monetize lead remyelination therapy
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Ram aiyarKorro bioDavid lucchinoFrequency therapeuticsOligonucleotide promoted editingFrequency therapeutic

Korro Bio and Frequency Therapeutics Announce Merger Agreement

Merger to create a Nasdaq-listed genetic medicines company focused on advancing Korro Bio’s wholly owned portfolio of RNA editing programs Lead program is a disease modifying therapy for patients with alpha-1 antitrypsin deficiency (AATD), with preclinical data showing an increase of normal A1AT protein to 85% of total protein in circulation Combined company is expected to have cash balance of approximately $170 million at close, which is expected to provide cash runway through several value-creating milestones and into 2026 Companies to host conference call today at 8:30 a.m. ET

United kingdomUnited statesRam aiyarSteve collettiVineet agarwalKorro bioShelby walkerTodd chappellVenkat krishnamurthyDavidl lucchinoStephanie engelsAlex silversteinPiper sandlerFidelity management research companyExchange commissionJp morgan securities

Frequency Therapeutics (FREQ) to Merge with Korro Bio

Frequency Therapeutics (FREQ) to Merge with Korro Bio
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPiper sandlerTodd chappellKorro bioStephanie engelsDavidl lucchinoAlex silversteinVenkat krishnamurthyShelby walkerVineet agarwalSteve collettiRam aiyarKorro bio incJp morgan securitiesVerition fund management